SAFETY

This study tests the MVA-BN mpox vaccine in 359 pregnant and postpartum women in the Democratic Republic of the Congo. Some women get the vaccine during pregnancy, others right after birth, and a small group gets it as an emergency shot after mpox exposure. Researchers will check…

This Phase 3 study is testing the MVA-BN mpox vaccine in 344 infants and children aged 4 to 24 months in the Democratic Republic of the Congo, a region heavily affected by mpox. Researchers are comparing a standard dose to a half-dose to see if the lower dose is still effective a…

This early-stage study tests a new treatment called RD06-04, which uses a patient's own immune cells modified to target and attack lupus-causing cells. The study involves 12 adults with moderate to severe lupus who have not responded well to standard treatments. The main goal is …

This study is a registry that will track 3,600 patients who need coronary angiography or intervention (like stenting) using the distal radial artery in the wrist. Researchers want to see how often the procedure is successful and how often complications occur. It does not test a n…

This study tracks the safety of the Pfizer COVID-19 vaccine (BNT162b2) in 12,000 Korean adults who received it as part of routine care. Researchers will record any side effects, including serious ones, for up to 28 days after each dose. The goal is to gather real-world safety dat…